BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,183 | -31.4% | 42,560 | -17.2% | 0.02% | -27.3% |
| Q2 2023 | $2,341,871 | -44.0% | 51,403 | -50.1% | 0.02% | -47.6% |
| Q1 2023 | $4,181,772 | -36.3% | 103,102 | -20.0% | 0.04% | -38.2% |
| Q4 2022 | $6,566,305 | -19.0% | 128,827 | -14.4% | 0.07% | -26.1% |
| Q3 2022 | $8,109,000 | -29.5% | 150,556 | -15.9% | 0.09% | -25.8% |
| Q2 2022 | $11,501,000 | -29.1% | 179,068 | -14.4% | 0.12% | -17.3% |
| Q1 2022 | $16,227,000 | -24.0% | 209,276 | -15.9% | 0.15% | -22.7% |
| Q4 2021 | $21,353,000 | -32.0% | 248,753 | -36.3% | 0.19% | -38.2% |
| Q3 2021 | $31,399,000 | -35.6% | 390,386 | -35.6% | 0.31% | -35.7% |
| Q2 2021 | $48,762,000 | -1.5% | 605,749 | +3.2% | 0.49% | -18.0% |
| Q1 2021 | $49,500,000 | +8.3% | 586,909 | +3.0% | 0.60% | -0.5% |
| Q4 2020 | $45,722,000 | -0.8% | 569,810 | -0.5% | 0.60% | -11.1% |
| Q3 2020 | $46,073,000 | -6.0% | 572,917 | +0.7% | 0.67% | -13.0% |
| Q2 2020 | $48,996,000 | +12.5% | 569,062 | +6.1% | 0.77% | -5.0% |
| Q1 2020 | $43,537,000 | +2.9% | 536,236 | +6.0% | 0.82% | +27.9% |
| Q4 2019 | $42,312,000 | -2.8% | 506,002 | +1.7% | 0.64% | -9.1% |
| Q3 2019 | $43,512,000 | +7.6% | 497,445 | +0.8% | 0.70% | +7.7% |
| Q2 2019 | $40,438,000 | +3.9% | 493,738 | +3.2% | 0.65% | +1.2% |
| Q1 2019 | $38,910,000 | +25.6% | 478,529 | +1.7% | 0.64% | +16.3% |
| Q4 2018 | $30,980,000 | -11.4% | 470,677 | +3.8% | 0.55% | +1.1% |
| Q3 2018 | $34,970,000 | +10.1% | 453,618 | +5.5% | 0.55% | +3.6% |
| Q2 2018 | $31,762,000 | +22.3% | 430,149 | +7.7% | 0.53% | +22.2% |
| Q1 2018 | $25,967,000 | +5.1% | 399,260 | +4.5% | 0.43% | +9.4% |
| Q4 2017 | $24,706,000 | +9.1% | 382,201 | +5.9% | 0.40% | +3.4% |
| Q3 2017 | $22,644,000 | +16.3% | 360,868 | +12.2% | 0.38% | +11.7% |
| Q2 2017 | $19,472,000 | +58.5% | 321,642 | +35.8% | 0.34% | +56.2% |
| Q1 2017 | $12,284,000 | +12.7% | 236,869 | -3.6% | 0.22% | +10.6% |
| Q4 2016 | $10,899,000 | -10.4% | 245,811 | -3.9% | 0.20% | -12.4% |
| Q3 2016 | $12,170,000 | +9.5% | 255,657 | +4.0% | 0.23% | -18.7% |
| Q2 2016 | $11,118,000 | -49.2% | 245,846 | -23.0% | 0.28% | -48.0% |
| Q1 2016 | $21,883,000 | +109.1% | 319,455 | +16.5% | 0.54% | +101.9% |
| Q4 2015 | $10,464,000 | +13.8% | 274,279 | -2.0% | 0.26% | +10.0% |
| Q3 2015 | $9,199,000 | -59.6% | 280,018 | -13.9% | 0.24% | -56.2% |
| Q2 2015 | $22,750,000 | +4.8% | 325,331 | +2.7% | 0.55% | +3.8% |
| Q1 2015 | $21,703,000 | -17.0% | 316,815 | -11.2% | 0.53% | -15.1% |
| Q4 2014 | $26,154,000 | -19.9% | 356,850 | -21.6% | 0.62% | -6.7% |
| Q3 2014 | $32,654,000 | +11.6% | 454,980 | +12.4% | 0.67% | +15.9% |
| Q2 2014 | $29,269,000 | -5.4% | 404,820 | -3.7% | 0.58% | -2.9% |
| Q1 2014 | $30,936,000 | +35.2% | 420,443 | +27.8% | 0.59% | -1.7% |
| Q4 2013 | $22,878,000 | +11.0% | 328,935 | +4.8% | 0.60% | -1.6% |
| Q3 2013 | $20,610,000 | +1.0% | 313,762 | +6.5% | 0.61% | -3.3% |
| Q2 2013 | $20,405,000 | +2.5% | 294,566 | +7.4% | 0.64% | +0.2% |
| Q1 2013 | $19,916,000 | +17.8% | 274,182 | +8.1% | 0.63% | +6.4% |
| Q4 2012 | $16,908,000 | +11.6% | 253,638 | +0.9% | 0.60% | +12.7% |
| Q3 2012 | $15,153,000 | +16.2% | 251,424 | +2.5% | 0.53% | +10.9% |
| Q2 2012 | $13,043,000 | -10.7% | 245,384 | +0.4% | 0.48% | -8.4% |
| Q1 2012 | $14,610,000 | +24.9% | 244,385 | +3.4% | 0.52% | +11.6% |
| Q4 2011 | $11,693,000 | -4.3% | 236,331 | +8.5% | 0.47% | -13.7% |
| Q3 2011 | $12,223,000 | +1.4% | 217,717 | +7.8% | 0.54% | +18.1% |
| Q2 2011 | $12,060,000 | +20.0% | 202,042 | +8.1% | 0.46% | +21.2% |
| Q1 2011 | $10,053,000 | +9.1% | 186,964 | +2.7% | 0.38% | +5.0% |
| Q4 2010 | $9,212,000 | +10.7% | 181,975 | +4.4% | 0.36% | +2.0% |
| Q3 2010 | $8,319,000 | +40.4% | 174,363 | +19.6% | 0.35% | +27.0% |
| Q2 2010 | $5,926,000 | -21.4% | 145,816 | +12.5% | 0.28% | -10.0% |
| Q1 2010 | $7,544,000 | +28.4% | 129,625 | +29.4% | 0.31% | +23.1% |
| Q4 2009 | $5,876,000 | +99.5% | 100,136 | +93.8% | 0.25% | +88.7% |
| Q3 2009 | $2,946,000 | +13.4% | 51,668 | +5.3% | 0.13% | +0.8% |
| Q2 2009 | $2,598,000 | +11.3% | 49,046 | +7.7% | 0.13% | -2.9% |
| Q1 2009 | $2,334,000 | – | 45,560 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |